
Safety of RLRL therapy for myopia reviewed
A recent review found no irreversible visual function loss or ocular structural damage in individuals undergoing repeated low-level red-light (RLRL) therapy for myopia. Analysing 20 studies (i

A recent review found no irreversible visual function loss or ocular structural damage in individuals undergoing repeated low-level red-light (RLRL) therapy for myopia. Analysing 20 studies (i

A small US trial of a sustained-release intravitreous implant found geographic atrophy (GA) lesion growth was two-thirds less in treated eyes compared to controls over three months. Inflammasom

US researchers found patients with thyroid eye disease receiving teprotumumab (Tepezza) were 24 times more likely to suffer hearing-related impairments. Writing in Ophthalmic Plastic and Reconstruct

Artificial intelligence (AI) is now a part of our daily lives – it's not just about predicting which movie you'll binge next, finding the fastest route home, or powering tools like ChatGPT. In our AI-driven world, where machine learning and algorithms have become familiar conveniences, there is a le

The inaugural Nelson event celebrating all things running, The Spectacle, was hailed a resounding success with 1,500 competitors and crowds lining the streets on a scorching hot summer’s day in December.

The authors of a study of low-dose atropine to treat myopia in European children said the results favour 0.05% over 0.01% nightly eye-drop use, despite more adverse events in the former group.

Heidelberg Engineering has announced the epithelial thickness module for its anterior segment imaging platform Anterion has received FDA clearance.

Eye Health Aotearoa (EHA) has appointed Dr Ayesha Verrall, MP and Labour Party spokesperson for health, and Sam Uffindell, MP and chair of the Health Select Committee, as its new Parliamentary Friends of Eye Health (PFEH) co-chairs.

The Australian team behind the Laser Intervention in the Early Stages of AMD (LEAD) study is now recruiting patients with age-related macular degeneration (AMD) who have early signs of atrophy or nascent geographic atrophy (nGA) for the new LIANA (laser intermediate AMD with nGA) study.

The National Party-led government remains committed to a national Clinical Priority Assessment Criteria (CPAC) score of 46 for cataract surgery, despite a growing waitlist and the outsourcing of the procedure to private practices being paused in some districts, confirmed Te Whatu Ora.

Gisborne Hospital’s ophthalmology research team is poised to pilot keratoconus screening after being awarded $39,918 by the Australian & New Zealand Eye Foundation (ANZEF).

The University of Auckland’s Associate Professor Stuti Misra has been awarded the prestigious American Academy of Optometry Foundation’s (AAOF) Outstanding Emerging Leader Award.